Resume

EXPERIENCE

CO-FOUNDER, HEAD OF BUSINESS DEVELOPMENT
FELIX BIOTECHNOLOGY

Developing bacteriophage tech to treat disease and modulate the microbiome.

September 2020 –
current

BLAVATNIK FELLOW IN ENTREPRENEURSHIP
YALE UNIVERSITY

Working with faculty to launch new ventures, with a focus on infectious disease, rare disease, and synthetic biology.

May 2019 –
August 2020

CONSULTANT
CLEARVIEW HEALTHCARE PARTNERS

Delivered strategic insights for clients, from biotech startups to large pharmaceutical companies.

January 2018 –
March 2019

WORLD TRAVELER

Circumnavigated Earth across 5 continents and 28 countries
in one year with a backpack. Blogged about it here.

October 2016 –
November 2017

DOCTORAL STUDENT
YALE UNIVERSITY

Worked with Dr. Farren Isaacs to develop biosecurity and biocontainment mechanisms for engineered organisms. Mentor for Yale iGEM for 5 years, pro-bono consultant and project manager for Yale Graduate Consulting Club for 2 years.

August 2011 –
October 2016

PUBLICATIONS

The case for biotech on Mars.
Nangle, S.N., Wolfson, M.Y., Hartsough, L., Ma, N.J., Mason, C.E., Merighi, M., Nathan, V., Silver, P.A., Simon, M., Swett, J., Thompson, D.B., Ziesack, M. Nature Biotechnology, 2020.

Organisms with alternative genetic codes resolve unassigned codons via mistranslation and ribosomal rescue.
Ma, N.J., Hemez, C.F., Barber, K.W., Rinehart, J., Isaacs, F.J. eLife, 2018.

Genomic Recoding Broadly Obstructs the Propagation of Horizontally Transferred Genetic Elements.
Ma, N.J., Isaacs, F.J. Cell Systems, 2016.

Merlin: Computer-Aided Oligonucleotide Design for Large Scale Genome Engineering with MAGE.
Quintin, M., Ma, N.J., Ahmed, S., Bhatia, S., Lewis, A., Isaacs, F., and Densmore, D. ACS Synthetic Biology, 2016.

A flexible codon in genomically recoded Escherichia coli permits programmable protein phosphorylation.
Pirman, N.L, Barber, K., Aerni, H., Ma, N.J., Haimovich, A.D., Rogulina, S., Isaacs, F.J., Rinehart, J. Nature Communications, 2015.

Evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids.
Amiram, M.A., Haimovich, A.D., Fan, C., Wang, Y.S., Moonan, D.W., Ma, N.J., Rovner, A.J., Nakamura, A., Söll, D., Isaacs, F.J. Nature Biotechnology, 2015.

Precise manipulation of bacterial chromosomes by conjugative assembly genome engineering.
Ma, N.J., Moonan, D.W. Isaacs, F.J. Nature Protocols, 2014.

MEDIA

Johnson & Johnson, 2021: Antimicrobial Resistance – Breakthrough Innovation and Breaking Barriers

Theia Healthcare, 2021: Spinning Out Innovation from Academia

Psychology Today, 2020: Amid COVID-19 Pandemic, How is Biotech Responding?

Falling Walls 2019: Breaking the Wall of Antibiotic Resistance with Felix Biotechnology

%d bloggers like this: